Harnessing the therapeutic power of cannabinoids
We want to have a positive impact on the lives of people living with debilitating conditions and to change the narrative about cannabis for good.
Our Science
OCT has a range of compounds in drug development, including proprietary cannabinoid derivatives, phytocannabinoids and completely new chemical entities (NCEs) that target the endocannabinoid system.
Meet the Team
With experience across pharmaceutical operations, R&D, intellectual property, law and finance, OCT’s team is committed to excellence. Together, we are passionate about delivering breakthrough therapies for life-threatening conditions with a significant unmet medical need.
Recent News
Follow our journey from early-stage discovery work to clinical trials as we aim to harness the therapeutic power of cannabinoids to develop new prescription medicines for people living with severe, chronic pain conditions and cancer.
